Mohamed Ben Sghaier

Dr. Mohamed Ben Sghaier


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
MSMohamed Ben Sghaier
Mohamed Ben Sghaier
APAlessandra Pagano
Alessandra Pagano
MMMohamed Mousslim
Mohamed Mousslim
YAYoussef Ammari
Youssef Ammari
HKHervé Kovacic
Hervé Kovacic
JLJosé Luis
José Luis

22 August 2012 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JBJihed Boubaker
Jihed Boubaker
MSMohamed Ben Sghaier
Mohamed Ben Sghaier
ISInes Skandrani
Ines Skandrani
KGKamel Ghedira
Kamel Ghedira
LCLeila Chekir-Ghedira
Leila Chekir-Ghedira
Background: In this report, the isorhamnetin 3-o-robinobioside and its original extract, the ethyl acetate extract, from Nitraria retusa leaves, were evaluated for their ability to induce antioxidant and antigenotoxic effects in human chronic myelogenous leukemia cell line. Methods: Nitraria retusa products properties were carried out by firstly evaluating their effects against lipid peroxidation induced by H2O2, using the thiobarbituric acid reactive substances species (TBARS) assay, and proceeding to the assay of cellular antioxidant activity, then doing the comet assay. Results: The isorhamnetin 3-o-robinobioside showed a protective effect against lipid peroxidation induced by H2O2. The same natural compound and ethyl acetate extract inhibited oxidation induced by 2,2′-azobis (2-amidinopropane) dihydrochloride in human chronic myelogenous leukemia cells with respectively 50% inhibitory concentration values of 0.225 mg/ml and 0.31 mg/ml, reflecting a significant antioxidant potential. The same two products inhibited the genotoxicity induced by hydroxyl radicals in the same human cell line (by 77.77% at a concentration of 800 μg/ml and by 80.55% at a concentration of 1000 μg/ml respectively). Conclusions: The i sorhamnetin 3- o-robinobioside and its original extract, the ethyl acetate extract, from Nitraria retusa leaves, have a great antioxidant and antigenotoxic potential on human chronic myelogenous leukemia cell line K562.

1 June 2016 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
MSMohamed Ben Sghaier
Mohamed Ben Sghaier
MIManel Ben Ismail
Manel Ben Ismail
IBInes Bouhlel
Ines Bouhlel
KGKamel Ghedira
Kamel Ghedira
LCLeila Chekir-Ghedira
Leila Chekir-Ghedira

1 January 2008 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
AAAfef Abdelwahed
Afef Abdelwahed
ISInes Skandrani
Ines Skandrani
SKSoumaya Kilani
Soumaya Kilani
ANA. Neffati
A. Neffati
MSMohamed Ben Sghaier
Mohamed Ben Sghaier
LCLeila Chekir-Ghedira
Leila Chekir-Ghedira
Mutagenic and antimutagenic activities against direct acting mutagens, nifuroxazide (NF) and sodium azide (SA), and indirect acting mutagen aflatoxin B1 (AFB1) of extracts prepared from aerial parts of Pituranthos tortuosus were investigated in bacterial assay systems (i.e., the Ames test with Salmonella typhimurium TA100, TA98, TA1538, TA1535, and the SOS chromotest with Escherichia coli PQ 37). It was found that all extracts obtained from P. tortuosus decreased the mutagenicity induced by AFB1 (10 μg/assay), SA (1.5 μg/assay), and NF (20 μg/assay). Ethyl acetate, acetone, methanol, and total oligomer flavenoid extracts exhibited the highest inhibition level of mutagenicity induced by the indirect mutagen AFB1. In addition, antiproliferative and apoptotic properties of these extracts have also been reported using two leukemia cell lines, L1210 and K562. The results revealed that all extracts showed a significant cytotoxic effect on these cell lines, and the effect was greater in the presence of human K562 chronic myelogenous leukemia cells, whereas they do not induce apoptosis.